Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
EGRX

Eagle Pharmaceuticals

$57.24

0.55 (0.97%)

17:15
11/15/19
11/15
17:15
11/15/19
17:15
Syndicate
Breaking Syndicate news story on Eagle Pharmaceuticals »

Eagle Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Tuesday
EGRX

Eagle Pharmaceuticals

$61.87

-1.24 (-1.96%)

06:56
11/12/19
11/12
06:56
11/12/19
06:56
Hot Stocks
Eagle Pharmaceuticals sees FY19 R&D spend $32.0M-$36.0M vs. $38.0M in FY18 »

Sees FY19 SG&A spend,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

EGRX

Eagle Pharmaceuticals

$61.87

-1.24 (-1.96%)

06:54
11/12/19
11/12
06:54
11/12/19
06:54
Earnings
Eagle Pharmaceuticals reports Q3 adjusted EPS 26c, consensus 43c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

Over a week ago
EGRX

Eagle Pharmaceuticals

$62.52

0.77 (1.25%)

04:55
10/22/19
10/22
04:55
10/22/19
04:55
Conference/Events
Eagle Pharmaceuticals management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

EGRX

Eagle Pharmaceuticals

$61.75

-0.65 (-1.04%)

04:55
10/21/19
10/21
04:55
10/21/19
04:55
Conference/Events
Eagle Pharmaceuticals management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

Over a month ago
EGRX

Eagle Pharmaceuticals

$60.76

0.66 (1.10%)

07:35
10/15/19
10/15
07:35
10/15/19
07:35
Conference/Events
Eagle Pharmaceuticals management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

EGRX

Eagle Pharmaceuticals

$59.18

0.11 (0.19%)

06:56
10/07/19
10/07
06:56
10/07/19
06:56
Hot Stocks
Eagle Pharmaceuticals says SymBio submits NDA for TREAKISYM RTD »

Eagle Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

Over a quarter ago
EGRX

Eagle Pharmaceuticals

$55.22

1.49 (2.77%)

07:07
08/08/19
08/08
07:07
08/08/19
07:07
Earnings
Eagle Pharmaceuticals reports Q2 adjusted EPS 86c, consensus 83c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

EGRX

Eagle Pharmaceuticals

$53.53

-0.11 (-0.21%)

06:54
08/05/19
08/05
06:54
08/05/19
06:54
Hot Stocks
Eagle Pharmaceuticals announces breast cancer product development plan »

Eagle Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

EGRX

Eagle Pharmaceuticals

$53.16

2.16 (4.24%)

06:56
05/07/19
05/07
06:56
05/07/19
06:56
Hot Stocks
Eagle Pharmaceuticals announces results from RYANODEX study »

Eagle Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.